Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.06.24	Is Pfizer Stock a Buy? (MotleyFool)
27.06.24	This Recent FDA Approval Is Bad News for Pfizer (MotleyFool)
27.06.24	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (RSS)
27.06.24	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (Businesswire)
26.06.24	Pfizer Declares Third-Quarter 2024 Dividend (Businesswire)
26.06.24	What's Going On With Pfizer Shares Wednesday? (Benzinga)
24.06.24	UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract (Benzinga)
24.06.24	Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster (MarketWatch)
19.06.24	Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis (Benzinga)
18.06.24	Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts (Businesswire)
18.06.24	Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb (MotleyFool)
18.06.24	Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine (MarketWatch)
17.06.24	Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? (Benzinga)
14.06.24	Is It Too Late to Buy Pfizer Stock? (MotleyFool)
14.06.24	ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma (Businesswire)
13.06.24	What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower (Benzinga)
12.06.24	Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy (Businesswire)
10.06.24	Spotlight on Pfizer: Analyzing the Surge in Options Activity (Benzinga)
05.06.24	Why Things Could Get Worse for Pfizer Stock Before They Get Better (MotleyFool)
03.06.24	Pfizer Unusual Options Activity For June 03 (Benzinga)
03.06.24	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
01.06.24	Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/?Refractory Diffuse Large B-cell Lymphoma (DLBCL) (Businesswire)
01.06.24	Is Pfizer the Best Dividend Stock for You? (MotleyFool)
31.05.24	Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer (Benzinga)
31.05.24	How To Earn $500 A Month From Pfizer Stock (Benzinga)
31.05.24	Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression (Businesswire)
31.05.24	Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors? (MotleyFool)
29.05.24	AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock (MotleyFool)
26.05.24	How Much Will Pfizer Pay Out in Dividends This Year? (MotleyFool)
23.05.24	Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 (Benzinga)
21.05.24	Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead? (MotleyFool)
20.05.24	Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute (Benzinga)
20.05.24	Pfizer Unusual Options Activity (Benzinga)
17.05.24	Moderna wins Covid jab patent dispute over Pfizer and BioNTech (Financial Times)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten